Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Initialising ...
Sato, Tatsuhiko; Furuta, Takuya; Liu, Y.*; Naka, Sadahiro*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Watabe, Tadashi*
EJNMMI Physics (Internet), 8, p.4_1 - 4_16, 2021/01
Times Cited Count：27 Percentile：87.37(Radiology, Nuclear Medicine & Medical Imaging)An individual dosimetry system including the function for calculating EQDX was developed based on PHITS coupled with the microdosimetric kinetic model. It enables us to predict the therapeutic and side effects of TAT based on the clinical data largely available from conventional external radiotherapy.
Br-
-methyl-phenylalanine for tumor PET imagingHanaoka, Hirofumi*; Ohshima, Yasuhiro; Suzuki, Yurika*; Yamaguchi, Aiko*; Watanabe, Shigeki; Uehara, Tomoya*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Ishioka, Noriko; Tsushima, Yoshito*; et al.
Journal of Nuclear Medicine, 56(5), p.791 - 797, 2015/05
Times Cited Count：22 Percentile：64.50(Radiology, Nuclear Medicine & Medical Imaging)Toyoda, Minoru*; Kaira, Kyoichi*; Ohshima, Yasuhiro; Ishioka, Noriko; Shino, Masato*; Sakakura, Koichi*; Takayasu, Yukihiro*; Takahashi, Katsumasa*; Tominaga, Hideyuki*; Oriuchi, Noboru*; et al.
British Journal of Cancer, 110(10), p.2506 - 2513, 2014/05
Times Cited Count：120 Percentile：95.19(Oncology)-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancerSuzuki, Shigemasa*; Kaira, Kyoichi*; Ohshima, Yasuhiro; Ishioka, Noriko; Soda, Makoto*; Yokobori, Takehiko*; Miyazaki, Tatsuya*; Oriuchi, Noboru*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; et al.
British Journal of Cancer, 110(8), p.1985 - 1991, 2014/04
Times Cited Count：27 Percentile：60.46(Oncology)Kaira, Kyoichi*; Sunose, Yutaka*; Ohshima, Yasuhiro; Ishioka, Noriko; Arakawa, Kazuhisa*; Ogawa, Tetsushi*; Sunaga, Noriaki*; Shimizu, Kimihiro*; Tominaga, Hideyuki*; Oriuchi, Noboru*; et al.
BMC Cancer, 13, p.482_1 - 482_12, 2013/10
Times Cited Count：84 Percentile：89.34(Oncology)
F]fluoro--methyl-D-tyrosine (D-[F]FAMT) as a novel amino acid tracer for positron emission tomographyOhshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
Annals of Nuclear Medicine, 27(4), p.314 - 324, 2013/05
Times Cited Count：20 Percentile：56.71(Radiology, Nuclear Medicine & Medical Imaging)F]fluoro--methyl-D-tyrosine (D-[F]FAMT) as a novel amino acid tracer for positron emission tomographyOhshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
no journal, ,
F]fluoro--methyl-D-tyrosine (D-[F]FAMT) as a novel amino acid tracer for positron emission tomographyOhshima, Yasuhiro; Hanaoka, Hirofumi*; Tominaga, Hideyuki*; Kanai, Yoshikatsu*; Kaira, Kyoichi*; Yamaguchi, Aiko*; Nagamori, Shushi*; Oriuchi, Noboru*; Tsushima, Yoshito*; Endo, Keigo*; et al.
no journal, ,
no abstracts in English
Br-bromo--methyl-L-phenylalanine as a novel Br-labeled PET tracerOhshima, Yasuhiro; Hanaoka, Hirofumi*; Suzuki, Yurika*; Yamaguchi, Aiko*; Watanabe, Shigeki; Uehara, Tomoya*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Ishioka, Noriko; Tsushima, Yoshito*; et al.
no journal, ,
no abstracts in English
Ohshima, Yasuhiro; Tominaga, Hideyuki*; Nagamori, Shushi*; Kanai, Yoshikatsu*; Oriuchi, Noboru*; Ishioka, Noriko
no journal, ,
Kaira, Kyoichi*; Toyoda, Minoru*; Ohshima, Yasuhiro; Oriuchi, Noboru*; Kanai, Yoshikatsu*; Oyama, Tetsunari*; Yamada, Masanobu*; Asao, Takayuki*; Chikamatsu, Kazuaki*
no journal, ,
